Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Winquist

Showing results (81-90 of 234) with videos related to

Pageof 24
Sort By:
Cancer Treatment Reviews|September 10, 2014
Temporal changes in the efficacy of chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck: a systematic review and meta-analysisEric Winquist, Intisar Al-Rasheedy, Anthony C Nichols, et al.
The Canadian Journal of Urology|November 15, 2002
Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guidelineRoanne Segal, Eric Winquist, Himu Lukka, et al.
Investigational New Drugs|July 22, 2005
Phase II study of the efficacy and safety of oral GD0039 in patients with locally advanced or metastatic renal cell carcinomaPhilip E Shaheen, Walter Stadler, Paul Elson, et al.
American Journal of Clinical Oncology|February 8, 2006
A phase I dose finding study of cisplatin, gemcitabine, and weekly docetaxel for patients with advanced transitional cell cancerAnna Tinker, Eric Winquist, Christina Canil, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 27, 2024
Case - Long-term remission after repeated courses of palliative radiotherapy in a patient with metastatic MiT family translocation renal cell carcinomaAruni Jayatilaka, Eric Winquist, Jacqueline Lebiadowski-Parish, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 27, 2019
Early experience with chemotherapy intensification for poor-prognosis metastatic germ cell cancer and unfavorable tumor marker declineAnupam Batra, Scott Ernst, Kylea Potvin, et al.
Breast Cancer Research and Treatment|April 19, 2014
Tamoxifen-associated hot flash severity is inversely correlated with endoxifen concentration and CYP3A4*22Simon D Baxter, Wendy A Teft, Yun-Hee Choi, et al.
Clinical Nuclear Medicine|June 11, 2020
Prostate Cancer Lymphangitic Pulmonary Carcinomatosis: Appearance on 18F-FDG PET/CT and 18F-DCFPyL PET/CTKatherine A Zukotynski, Hossein Jadvar, Kylea Potvin, et al.
Urologic Oncology|May 24, 2005
A Phase II study of oxaliplatin in urothelial cancerEric Winquist, Everett Vokes, Malcolm J Moore, et al.
The Journal of Urology|June 17, 2008
Multicenter phase II study of combined neoadjuvant docetaxel and hormone therapy before radical prostatectomy for patients with high risk localized prostate cancerKim N Chi, Joseph L Chin, Eric Winquist, et al.
Pageof 24

Showing results (81-90 of 234) with videos related to

Sort By:
Pageof 24
Cancer Treatment Reviews|September 10, 2014
Temporal changes in the efficacy of chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck: a systematic review and meta-analysisEric Winquist, Intisar Al-Rasheedy, Anthony C Nichols, et al.
The Canadian Journal of Urology|November 15, 2002
Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guidelineRoanne Segal, Eric Winquist, Himu Lukka, et al.
Investigational New Drugs|July 22, 2005
Phase II study of the efficacy and safety of oral GD0039 in patients with locally advanced or metastatic renal cell carcinomaPhilip E Shaheen, Walter Stadler, Paul Elson, et al.
American Journal of Clinical Oncology|February 8, 2006
A phase I dose finding study of cisplatin, gemcitabine, and weekly docetaxel for patients with advanced transitional cell cancerAnna Tinker, Eric Winquist, Christina Canil, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 27, 2024
Case - Long-term remission after repeated courses of palliative radiotherapy in a patient with metastatic MiT family translocation renal cell carcinomaAruni Jayatilaka, Eric Winquist, Jacqueline Lebiadowski-Parish, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 27, 2019
Early experience with chemotherapy intensification for poor-prognosis metastatic germ cell cancer and unfavorable tumor marker declineAnupam Batra, Scott Ernst, Kylea Potvin, et al.
Breast Cancer Research and Treatment|April 19, 2014
Tamoxifen-associated hot flash severity is inversely correlated with endoxifen concentration and CYP3A4*22Simon D Baxter, Wendy A Teft, Yun-Hee Choi, et al.
Clinical Nuclear Medicine|June 11, 2020
Prostate Cancer Lymphangitic Pulmonary Carcinomatosis: Appearance on 18F-FDG PET/CT and 18F-DCFPyL PET/CTKatherine A Zukotynski, Hossein Jadvar, Kylea Potvin, et al.
Urologic Oncology|May 24, 2005
A Phase II study of oxaliplatin in urothelial cancerEric Winquist, Everett Vokes, Malcolm J Moore, et al.
The Journal of Urology|June 17, 2008
Multicenter phase II study of combined neoadjuvant docetaxel and hormone therapy before radical prostatectomy for patients with high risk localized prostate cancerKim N Chi, Joseph L Chin, Eric Winquist, et al.
Pageof 24